|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500107700 |
|
最近更新日期: Date of Last Refreshed on: |
2025-08-18 09:24:19 |
|
注册时间: Date of Registration: |
2025-08-18 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
主观认知下降老年人社区非药物干预方案的构建与初步应用 |
|
Public title: |
Construction and preliminary application of the community-based non-pharmacological intervention program for older adults with subjective cognitive decline |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
主观认知下降老年人社区团体非药物干预方案的构建与初步应用 |
|
Scientific title: |
Construction and preliminary application of the community-based group non-pharmacological intervention program for older adults with subjective cognitive decline |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
才智 |
研究负责人: |
唐国华 |
|
Applicant: |
Zhi Cai |
Study leader: |
Guohua Tang |
|
申请注册联系人电话: Applicant telephone: |
+86 159 4183 9112 |
研究负责人电话:
Study leader's |
+86 189 4022 6278 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
czcaizhi@163.com |
研究负责人电子邮件: Study leader's E-mail: |
tgh204203@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
中国辽宁省沈阳市沈北新区蒲河路77号 |
研究负责人通讯地址: |
中国辽宁省沈阳市沈北新区蒲河路77号 |
|
Applicant address: |
No. 77, Puhe Street, Shenbei New District , Shenyang, Liaoning, China |
Study leader's address: |
No. 77, Puhe Street, Shenbei District , Shenyang, Liaoning, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国医科大学 |
||
|
Applicant's institution: |
China Medical University |
||
|
研究负责人所在单位: |
中国医科大学 |
||
|
Affiliation of the Leader: |
China Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦审[2025]178号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国医科大学医学伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of China Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-05-07 00:00:00 | ||
|
伦理委员会联系人: |
孙老师 |
||
|
Contact Name of the ethic committee: |
Teacher Sun |
||
|
伦理委员会联系地址: |
辽宁省沈阳市沈北新区蒲河路77号 |
||
|
Contact Address of the ethic committee: |
77 Puhe Road, Shenbei New District, Shenyang, Liaoning |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 24 3193 9080 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
China Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
辽宁省沈阳市沈北新区蒲河路77号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
77 Puhe Road, Shenbei New District, Shenyang, Liaoning |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
博士研究生培养经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Doctoral student training funds |
||||||||||||||||||||||
|
研究疾病: |
主观认知下降 |
||||||||||||||||||||||
|
Target disease: |
Subjective cognitive decline |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
对主观认知下降老年人社区非药物干预方案进行初步应用并探讨其效果 |
||||||||||||||||||||||
|
Objectives of Study: |
The community-based non-pharmacological intervention program for older adults with subjective cognitive decline was preliminarily applied and its effect was explored |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄>=60岁; 2.符合SCD筛查标准:中文版主观认知下降问卷(Subjective Cognitive Decline Questionnaire,SCD-Q9)评分>=5 分;无客观认知功能损害,通过蒙特利尔认知功能评估量表(Montreal Cognitive Assessment, MoCA)和简易精神状态检查量表 (Mini-Mental State Examination,MMSE) 确定;日常生活能力未受影响; 3.最近半年内未从事规律运动锻炼和认知活动等干预; 4.知情同意,自愿参加。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Age>=60 years old; 2. Meet the SCD screening criteria: > score of the Chinese version of the Subjective Cognitive Decline Questionnaire (SCD-Q9). =5 points; No objective cognitive impairment, as determined by the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE); The ability to perform daily activities is not affected; 3. Have not engaged in regular exercise and cognitive activities in the past six months; 4. Informed consent and voluntary participation. |
||||||||||||||||||||||
|
排除标准: |
1.任何其他神经退行性或重大精神疾病(轻度认知障碍或痴呆等); 2.任何严重或不稳定的内科疾病(即不稳定或严重哮喘或心血管疾病,活动性胃溃疡,或严重的肝脏或肾脏疾病或高血压无法控制者); 3.有严重的焦虑、抑郁; 4.具有运动禁忌症、色盲或者文化程度过低不能配合测试者; 5.正在参加其它研究试验者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Any other neurodegenerative or major mental illness (mild cognitive impairment or dementia, etc.); 2. Any serious or unstable medical illness (i.e., unstable or severe asthma or cardiovascular disease, active gastric ulcer, or severe liver or kidney disease or uncontrollable hypertension); 3. Severe anxiety and depression; 4. Those who have contraindications to exercise, color blindness, or too low education to cooperate with the test; 5. Those who are participating in other research trials. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-08-18 00:00:00至 To 2026-09-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-08-18 00:00:00 至 To 2026-05-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |